Giovanni Traverso

The paper analyzes CGM data to understand hypoglycemia kinetics in T1D patients, leading to the development of new glucagon delivery systems for improved therapy.

This study identifies small molecules that selectively bind to mucins in the gastrointestinal tract, enhancing localized drug delivery to the small intestine and stomach.

This paper introduces CO-GEMs as a multifunctional adjunct to HIPEC, improving efficacy, preventing adhesions, and reducing nephrotoxicity in ovarian cancer models.

The paper develops a bioresorbable implant system for long-term contraception that improves drug delivery efficiency and reduces the need for surgical intervention.

This paper develops e-GLUE, an electroadhesive hydrogel interface that enables prolonged mucosal retention and demonstrates its utility in GI theranostics.

This paper develops an ingestible, battery-free robotic interface for chronic gut electrostimulation, showing it can modulate ghrelin levels and has potential for treating gastrointestinal conditions.

This study develops thermo-responsive hydrogels that target inflamed colon mucosa for IBD treatment by exploiting charge-mediated interactions and thermo-responsiveness.

This paper develops an ingestible capsule that detects short-lived inflammatory biomarkers in the GI tract using genetically engineered probiotic biosensors and wireless readout technology.